Testosterone Enanthate
Enanthate · TESTOSTERONE ENANTATE · Testosterone Enanthat · Testosterone Ethanate · Testosterone enthate · Testo E · Testostroval · Testosterone oenanthate
식별자 및 물리적 특성
| CAS No. | 315-37-7 |
|---|---|
| 분자식 | C26H40O3 |
| 평균 분자량 | 400.6 g/mol |
| 단동위원소 질량 | 400.29774514 g/mol |
| SMILES | CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C |
| InChIKey | VOCBWIIFXDYGNZ-IXKNJLPQSA-N |
| PubChem CID | 9416 |
| ChEMBL | CHEMBL1200335 |
| ChEBI | CHEBI:9464 |
| EC No. | 206-253-5 |
| DTXSID | DTXSID701016540 |
화학 및 물리적 성질
| XLogP | 6.3 |
|---|---|
| 극성 표면적 | 43.4 |
| 수소 결합 공여자 수 | 0 |
| 수소 결합 수용자 수 | 3 |
| 회전 가능 결합 수 | 7 |
| 무거운 원자 수 | 29 |
| 형식 전하 | 0 |
| 복잡도 | 679 |
| 의약품 | Pharmaceuticals -> Listed in ZINC15 |
| 지질 | Lipids -> Sterol Lipids [ST] -> Steroids [ST02] -> C19 steroids (androgens) and derivatives [ST0202] |
| 용해도 | Insoluble물에 거의 녹지 않고 무수 에탄올에 잘 녹으며 지방유에 잘 녹습니다. |
| Human Drugs | FDA approved drugs -> Active ingredientPharmaceuticals |
| Endocrine Disruptors | Potential endocrine disrupting compound |
| 녹는점 | 34-39ºC36 - 37.5 °C34-39°C |
| Physical Description | Solid |
| 끓는 점 | 463.22°C (rough estimate) |
| 밀도 | 1.0562 (rough estimate) |
| 굴절률 | 1.4700 (estimate) |
| 저장 조건 | 2-8°C |
| 물리적 상태 | powder |
| 색상 | white to beige |
| InChI | InChI=1/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/s3 |
| InChIKey | VOCBWIIFXDYGNZ-IXKNJLPQSA-N |
| SMILES | [C@@]12([H])CCC3=CC(=O)CC[C@]3(C)[C@@]1([H])CC[C@]1(C)[C@H](CC[C@@]21[H])OC(=O)CCCCCC |&1:0,10,12,16,18,21,r| |
| NIST | Testosterone enanthate(315-37-7) |
화학적 성질
White or yellowish-white, crystalline powder.
안전 및 규제
| GHS 분류 | DangerH302 (96.8%): Harmful if swallowed [Warning Acute toxicity, oral]P203, P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P318, P321, P330, P362+P364, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 62 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| 규제 정보 | Hazard Traits - Developmental Toxicity |
| 기타 안전 정보 | IMAP assessments - Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17.beta.)-: Environment tier I assessment |
| Hazard Classes and Categories | Acute Tox. 4 (96.8%) |
| Drug Induced Liver Injury | Drug Induced Liver Injury Rank (DILIrank 2.0)Testosterone enanthatevMost-DILI-concern8Warnings & precautionsDOI:10.1016/j.drudis.2016.02.015 |
| 수질 위해 등급(WGK) | 3 |
| RTECS 번호 | XA3080000 |
| 독성 | man,TDLo,intramuscular,7519mg/kg/5W- (7519mg/kg),LUNGS, THORAX, OR RESPIRATION: DYSPNEA,New England Journal of Medicine. Vol. 308, Pg. 508, 1983. |
| 관세 코드 | 2937290000 |
| 위험 문구(R) | 45-63 |
| 위험 표시 | T |
| 안전 문구(S) | 53-22-36/37/39-45 |
| 위험 등급 | Acute Tox. 4 OralCarc. 1BRepr. 2 |
| 저장 분류 | 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects |
용도
개요
Testosterone enanthate (Item No. 22546) is an analytical reference standard categorized as an anabolic androgenic steroid. It is an ester of the naturally occurring androgen, testosterone (Item Nos. 15645 | ISO60154) with a longer half-life. Formulations containing testosterone enanthate have been tested for use in hypogonadism and as a potential male contraceptive. Formulations containing it have been associated with higher levels of total cholesterol, low density lipoproteins, and triglycerides and lower levels of high density lipoproteins. Anabolic steroids, including testosterone enanthate, have been used to enhance physical performance in racehorses and athletes, and methods to detect steroids, their derivatives, and their metabolites have been developed. This product is intended for research and forensic applications.
용도
Testosterone Enanthate is a derivative of testosterone (T155000), the principal hormone of the testes, produced by the interstitial cells.